BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33010252)

  • 41. Diagnosis and classification of celiac disease and gluten sensitivity.
    Tonutti E; Bizzaro N
    Autoimmun Rev; 2014; 13(4-5):472-6. PubMed ID: 24440147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical profile of patients with seronegative celiac disease.
    Rahmanipour E; Ghorbani M; Ganji A; Mirzaei Z; Ghavami V; Shahbazkhani B; Attarian F; Amiri M
    Gastroenterol Hepatol Bed Bench; 2023; 16(2):203-209. PubMed ID: 37554750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
    Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
    Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?
    Bannister EG; Cameron DJ; Ng J; Chow CW; Oliver MR; Alex G; Catto-Smith AG; Heine RG; Webb A; McGrath K; Simpson D; Hardikar W
    Am J Gastroenterol; 2014 Sep; 109(9):1478-83. PubMed ID: 25070050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge.
    Martins C; Teixeira C; Ribeiro S; Trabulo D; Cardoso C; Mangualde J; Freire R; Alves AL; Gamito É; Cremers I; Oliveira AP
    Case Rep Gastrointest Med; 2016; 2016():6392028. PubMed ID: 27803820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Celiac disease serology in dermatitis herpetiformis. Which is the best option for detecting gluten sensitivity?
    Sugai E; Smecuol E; Niveloni S; Vázquez H; Label M; Mazure R; Czech A; Kogan Z; Mauriño E; Bai JC
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):197-201. PubMed ID: 17225447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical analysis of gluten-related disease].
    Diao M; Bao J; Xu Y
    Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):884-9. PubMed ID: 25586360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic utility of deamidated gliadin peptide antibody in celiac disease compared to anti-tissue transglutaminase and IgA- endomysium antibodies.
    Sayed SK; Imam HM; Mahran AM; Refaiy AM
    Egypt J Immunol; 2012; 19(2):41-52. PubMed ID: 23885406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic performance of three serologic tests in childhood celiac disease.
    Bufler P; Heilig G; Ossiander G; Freudenberg F; Grote V; Koletzko S
    Z Gastroenterol; 2015 Feb; 53(2):108-14. PubMed ID: 25668712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients with mild enteropathy have apoptotic injury of enterocytes similar to that in advanced enteropathy in celiac disease.
    Das P; Gahlot GP; Mehta R; Makharia A; Verma AK; Sreenivas V; Panda SK; Ahuja V; Gupta SD; Makharia GK
    Dig Liver Dis; 2016 Nov; 48(11):1290-1295. PubMed ID: 27378705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Celiac Disease in Children: A 2023 Update.
    Bolia R; Thapar N
    Indian J Pediatr; 2024 May; 91(5):481-489. PubMed ID: 37289309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease.
    Conti V; Leone MC; Casato M; Nicoli M; Granata G; Carlesimo M
    Eur Ann Allergy Clin Immunol; 2015 Mar; 47(2):54-7. PubMed ID: 25781195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
    Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
    Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serological screening for celiac disease in symptomatic 12 to 36 month-old children.
    Modelli IC; Gandolfi L; Almeida RC; Araújo GM; Picanço Mde A; Pratesi R
    Arq Gastroenterol; 2010; 47(1):61-5. PubMed ID: 20520977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.
    Olen O; Gudjónsdóttir AH; Browaldh L; Hessami M; Elvin K; Liedberg AS; Neovius M; Grahnquist L
    J Pediatr Gastroenterol Nutr; 2012 Dec; 55(6):695-700. PubMed ID: 22722680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of Subsequent Celiac Disease Seropositivity in Patients Diagnosed with Duodenal Villus Atrophy on Upper Endoscopy.
    Ching CK; Lyudmer M; Lewis S; Krishnareddy S; Green PHR; Lebwohl B
    Dig Dis Sci; 2024 Mar; 69(3):876-883. PubMed ID: 38112838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased Detection of Celiac Disease With Measurement of Deamidated Gliadin Peptide Antibody Before Endoscopy.
    Mooney PD; Wong SH; Johnston AJ; Kurien M; Avgerinos A; Sanders DS
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1278-1284.e1. PubMed ID: 25632807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease.
    Agardh D
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1276-81. PubMed ID: 17683995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.